← Leaderboards
Caroline A Owen
University Of Utah
$6,770,438
Attributed
$9,241,901
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $964.4K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$9,241,901 · 5
By mechanism
R01$8,520,427 · 3
R21$456,221 · 1
P01$265,253 · 1
Top collaborators
- Kevin S Harrod5 shared
- Bruce D Levy2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsLungMediatingInjuryIn VitroLung InflammationMatrix MetalloproteinasesNeutrophilCleaved CellMorbidity - Disease RateMortality Vital StatisticsSamplingProteinsEpithelial CellsInhibitor/AntagonistPlayGelatinase BExtracellular Matrix ProteinsHuman SubjectProteolysisPeptide HydrolasesBinding (Molecular Function)PreventGene Targeting
Grant awards (20)
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections$850,154
R01 · FY2018 · AI
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections$955,998
R01 · FY2017 · AI
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections$964,377
R01 · FY2016 · AI
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections$717,682
R01 · FY2015 · AI
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections$852,665
R01 · FY2014 · AI
Novel Anti-inflammatory Activities For ADAM8 In Pulmonary Emphysema$159,546
R21 · FY2013 · HL · contact PI
Novel Anti-inflammatory Activities For ADAM8 In Pulmonary Emphysema$296,675
R21 · FY2012 · HL · contact PI
Integrated Murine Models of COPD$265,253
P01 · FY2011 · HL · contact PI
Novel Roles for ADAM15 in Acute Lung Injury$400,620
R01 · FY2010 · HL · contact PI
Novel Roles for ADAM15 in Acute Lung Injury$401,694
R01 · FY2009 · HL · contact PI
Novel Roles for ADAM15 in Acute Lung Injury$402,738
R01 · FY2008 · HL · contact PI
Novel Roles for MMP-8 in Acute Lung Injury$382,828
R01 · FY2008 · HL · contact PI
Novel Roles for ADAM15 in Acute Lung Injury$403,750
R01 · FY2007 · HL · contact PI
Novel Roles for MMP-8 in Acute Lung Injury$382,828
R01 · FY2007 · HL · contact PI
Novel Roles for MMP-8 in Acute Lung Injury$394,262
R01 · FY2006 · HL · contact PI
Novel Roles for MMP-8 in Acute Lung Injury$402,041
R01 · FY2005 · HL
LOCALIZATION AND ACTIVATION OF METALLOPROTEINASES$389,803
R01 · FY2002 · HL
LOCALIZATION AND ACTIVATION OF METALLOPROTEINASES$224,000
R01 · FY2001 · HL
LOCALIZATION AND ACTIVATION OF METALLOPROTEINASES$90,145
R01 · FY2001 · HL
LOCALIZATION AND ACTIVATION OF METALLOPROTEINASES$304,842
R01 · FY2000 · HL